The 2009 Oncology Highlights: News from The 2009 Annual Oncology Meeting series is the premier venue for many of the world’s top oncologists and hematologists to summarize and interpret the most clinically significant data released from The Annual Oncology Meeting. The faculty is comprised of local and internationally renowned experts who will present and analyze the most current clinical data. In addition to several question and answer periods, the audience will be able to interact by way of an audience response system.

• Leukemias, myelodyplasia, and transplantation
• Lymphomas
• Myelomas and plasma cell disorders
• Genitourinary cancers
• Gastrointestinal cancers
• Melanoma and skin cancers
• Head and neck cancers
• Gynecologic cancers
• Breast cancer
• Lung cancer

Physicians
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex, LLC designates this educational activity for a maximum 6.25 of AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity

Pharmacists
Imedex, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This course (Universal Program Number 408-000-09-001-L01-P) has been approved for a maximum of 6.25 contact hours (0.625 CEUs). No partial credit will be awarded. Participants must complete an evaluation form and credit request form at the conclusion of the activity. Statements of credit will be issued electronically (PDF) and emailed within six weeks of
the conclusion of the activity. There is a fee to participate in this activity.

Nurses
This program has been approved by the American Association of Critical Care Nurses (AACN) for 6.25 Contact Hours, CERP Category A, File number 00015390.

“I attend yearly and think these conferences are excellent”

“In one day we get the practical and useful clinical research and knowledge to apply in our practice”